8-K: Chemed Reports Strong Q3 2026 Results, VITAS Drives Growth

Chemed Corporation announced robust third-quarter 2026 financial results, highlighted by significant revenue and earnings growth in its VITAS Healthcare segment.

Summary

• Chemed Corporation reported strong third-quarter 2026 financial results, with consolidated revenue increasing by 10.6% to $690.9 million.
• GAAP Diluted Earnings-per-Share (EPS) rose by 22.2% to $5.45, and Adjusted Diluted EPS increased by 28.1% to $6.75.
• The VITAS segment saw a 12.2% increase in Net Patient Revenue to $457.4 million, driven by a 9.4% rise in Average Daily Census (ADC) and a 7.2% increase in admissions.
• VITAS Net Income, excluding discrete items, grew by 44.7% to $70.8 million, and Adjusted EBITDA (excluding Medicare Cap) increased by 31.4% to $92.5 million.
• Roto-Rooter segment revenue grew by 7.5% to $233.5 million, though Net Income declined by 1.8% to $33.3 million and Adjusted EBITDA decreased by 2.5% to $48.2 million.
• The company expects to be at or slightly above the high-end of its full-year 2026 adjusted EPS guidance.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong growth in VITAS and solid revenue increases in Roto-Rooter, despite some margin pressure in the latter. The company is also on track to meet or exceed its full-year EPS guidance.

Positives

• Consolidated revenue increased by 10.6% to $690.9 million.
• GAAP Diluted EPS increased by 22.2% to $5.45.
• Adjusted Diluted EPS increased by 28.1% to $6.75.
• VITAS Net Patient Revenue increased by 12.2% to $457.4 million.
• VITAS Average Daily Census (ADC) increased by 9.4% to 24,428.
• VITAS Admissions increased by 7.2% to 18,995.
• VITAS Net Income (excluding discrete items) increased by 44.7% to $70.8 million.
• VITAS Adjusted EBITDA (excluding Medicare Cap) increased by 31.4% to $92.5 million, with a margin of 20.2% (up 318 basis points).
• Roto-Rooter revenue increased by 7.5% to $233.5 million.
• The company is on track to meet or exceed its full-year 2026 adjusted EPS guidance.

Negatives

• Roto-Rooter Net Income (excluding discrete items) declined by 1.8% to $33.3 million.
• Roto-Rooter Adjusted EBITDA declined by 2.5% to $48.2 million.
• Roto-Rooter Adjusted EBITDA margin declined by 213 basis points to 20.6%.
• Roto-Rooter's selling, general and administrative expenses increased by 17.1% compared to the prior-year quarter.
• VITAS experienced a 25-basis point negative impact on revenue growth from acuity mix shift.

Risks

• The impact of laws and regulations on Chemed's operations, including Medicare Cap and Medicare reimbursement rates.
• Chemed's estimates of the effect of Medicare Cap on VITAS revenues and future prospects.
• Chemed's expectations regarding VITAS patient mix.
• Chemed's expectations regarding demand for Roto-Rooters services.
• Potential for future Medicare Cap billing limitations, with five provider numbers currently having a total limitation of $6.1 million.

Future Outlook

Chemed estimates it will be at or slightly above the high-end of its full-year 2026 adjusted EPS guidance, which was previously issued in conjunction with its second quarter 2026 earnings release.

Management Comments

• Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nations largest providers of end-of-life care, and Roto-Rooter, the nations largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2026, versus the comparable prior-year period.
• Based on the Companys financial results through September 30, 2026, we estimate that we will be at or slightly above the high-end of our full-year 2026 adjusted EPS guidance issued in conjunction with our press release, dated July 28, 2026, discussing our second quarter 2026 earnings.
• Further operational detail will be provided during the investor conference call.

Industry Context

StockSavvy.ai notes that the strong performance in the hospice care sector (VITAS) aligns with demographic trends of an aging population and increasing demand for end-of-life services. The moderate growth in plumbing services (Roto-Rooter) reflects ongoing demand for essential home and commercial maintenance, though margin pressures may indicate increased competition or operational costs.

Comparison to Industry Standards

• VITAS's 12.2% revenue growth and 31.4% Adjusted EBITDA growth in the hospice sector outpace general healthcare service industry growth rates.
• Roto-Rooter's 7.5% revenue growth is solid for the plumbing and drain cleaning sector, but the decline in Adjusted EBITDA margin suggests it may be underperforming against peers who are effectively managing costs or passing them on to consumers.
• The company's Adjusted Diluted EPS growth of 28.1% is a strong indicator of profitability, potentially exceeding industry averages for diversified service companies.

Stakeholder Impact

• Shareholders: Positive impact due to increased earnings per share and the company's expectation to meet or exceed full-year guidance, potentially leading to stock price appreciation.
• Employees: Continued growth in VITAS may lead to increased employment opportunities in healthcare services. Roto-Rooter's operational performance could influence employee compensation and bonuses.
• Customers: Continued service provision from both VITAS and Roto-Rooter. Potential for price adjustments in Roto-Rooter services due to margin pressures.
• Creditors: The company's debt levels and credit agreement provide a framework for financial obligations. Strong performance generally supports creditworthiness.

Next Steps

• Chemed will host a conference call and webcast on October 28, 2026, at 10 a.m. ET to discuss quarterly results and provide business updates.
• Further operational details will be provided during the investor conference call.

Key Dates

Recommendation

The strong performance, particularly in VITAS, and the positive outlook for full-year EPS are encouraging. However, the margin decline in Roto-Rooter warrants caution. A 'hold' recommendation reflects a balanced view, awaiting further clarity on Roto-Rooter's margin trends and sustained performance across both segments.

Keywords

hospice care, end-of-life care, plumbing services, drain cleaning, healthcare services, revenue growth, earnings per share, EBITDA